The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)

Bradley H. Smith, Daniel Waschbusch, Michael T. Willoughby, Steven Evans

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Studies examining interventions for adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) were reviewed to evaluate their efficacy. These efficacy findings were supplemented with a preliminary system for judging safety and practicality. Results suggest that the stimulant drug methylphenidate (MPH) is safe and well-established empirically, but has some problems with inconvenience and noncompliance. Preliminary research supports the efficacy, safety, and practicality of some psychotherapeutic interventions, including behavioral classroom interventions, note-taking training, and family therapy. Treatment with tricyclic antidepressants was judged to have minimal empirical support and debatable safety. Very little is known about long-term effectiveness of treatments, long-term compliance, or multimodal treatments for adolescents such as stimulants plus behavior therapy.

Original languageEnglish (US)
Pages (from-to)243-267
Number of pages25
JournalClinical Child and Family Psychology Review
Volume3
Issue number3
DOIs
StatePublished - Jan 1 2000

Fingerprint

ADHD
Attention Deficit Disorder with Hyperactivity
adolescent
Safety
behavior therapy
Combined Modality Therapy
Methylphenidate
Family Therapy
Behavior Therapy
Tricyclic Antidepressive Agents
family therapy
Compliance
Therapeutics
drug
classroom
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Education
  • Developmental and Educational Psychology
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

@article{2a41e397d9e645219bfaa7d35f0c1d7d,
title = "The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)",
abstract = "Studies examining interventions for adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) were reviewed to evaluate their efficacy. These efficacy findings were supplemented with a preliminary system for judging safety and practicality. Results suggest that the stimulant drug methylphenidate (MPH) is safe and well-established empirically, but has some problems with inconvenience and noncompliance. Preliminary research supports the efficacy, safety, and practicality of some psychotherapeutic interventions, including behavioral classroom interventions, note-taking training, and family therapy. Treatment with tricyclic antidepressants was judged to have minimal empirical support and debatable safety. Very little is known about long-term effectiveness of treatments, long-term compliance, or multimodal treatments for adolescents such as stimulants plus behavior therapy.",
author = "Smith, {Bradley H.} and Daniel Waschbusch and Willoughby, {Michael T.} and Steven Evans",
year = "2000",
month = "1",
day = "1",
doi = "10.1023/A:1026477121224",
language = "English (US)",
volume = "3",
pages = "243--267",
journal = "Clinical Child and Family Psychology Review",
issn = "1096-4037",
publisher = "Kluwer Academic Publishers",
number = "3",

}

The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD). / Smith, Bradley H.; Waschbusch, Daniel; Willoughby, Michael T.; Evans, Steven.

In: Clinical Child and Family Psychology Review, Vol. 3, No. 3, 01.01.2000, p. 243-267.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)

AU - Smith, Bradley H.

AU - Waschbusch, Daniel

AU - Willoughby, Michael T.

AU - Evans, Steven

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Studies examining interventions for adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) were reviewed to evaluate their efficacy. These efficacy findings were supplemented with a preliminary system for judging safety and practicality. Results suggest that the stimulant drug methylphenidate (MPH) is safe and well-established empirically, but has some problems with inconvenience and noncompliance. Preliminary research supports the efficacy, safety, and practicality of some psychotherapeutic interventions, including behavioral classroom interventions, note-taking training, and family therapy. Treatment with tricyclic antidepressants was judged to have minimal empirical support and debatable safety. Very little is known about long-term effectiveness of treatments, long-term compliance, or multimodal treatments for adolescents such as stimulants plus behavior therapy.

AB - Studies examining interventions for adolescents diagnosed with attention-deficit/hyperactivity disorder (ADHD) were reviewed to evaluate their efficacy. These efficacy findings were supplemented with a preliminary system for judging safety and practicality. Results suggest that the stimulant drug methylphenidate (MPH) is safe and well-established empirically, but has some problems with inconvenience and noncompliance. Preliminary research supports the efficacy, safety, and practicality of some psychotherapeutic interventions, including behavioral classroom interventions, note-taking training, and family therapy. Treatment with tricyclic antidepressants was judged to have minimal empirical support and debatable safety. Very little is known about long-term effectiveness of treatments, long-term compliance, or multimodal treatments for adolescents such as stimulants plus behavior therapy.

UR - http://www.scopus.com/inward/record.url?scp=0040519853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0040519853&partnerID=8YFLogxK

U2 - 10.1023/A:1026477121224

DO - 10.1023/A:1026477121224

M3 - Article

C2 - 11225739

AN - SCOPUS:0040519853

VL - 3

SP - 243

EP - 267

JO - Clinical Child and Family Psychology Review

JF - Clinical Child and Family Psychology Review

SN - 1096-4037

IS - 3

ER -